hUC-MSCs treatment (high dose)

BIOLOGICAL2 trials

Sponsors

Shenzhen Beike Bio-Technology Co., Ltd., Shenzhen Wingor Biotechnology Co., Ltd.

Conditions

Acute Ischemic Stroke AISSystemic Lupus Erythematosus (SLE)

Phase 1

Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells

RecruitingNCT07041801

Shenzhen Beike Bio-Technology Co., Ltd.Systemic Lupus Erythematosus (SLE)

Start: 2025-06-28End: 2027-12-28Target: 58Updated: 2025-06-27

Phase 2

A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS

RecruitingNCT07084012

Shenzhen Wingor Biotechnology Co., Ltd.Acute Ischemic Stroke AIS

Start: 2025-08-27End: 2028-12-30Target: 60Updated: 2026-07-29